Resveratrol in the foodomics era: 1:25,000

被引:20
作者
Khakimov, Bekzod [1 ]
Engelsen, Soren Balling [1 ]
机构
[1] Univ Copenhagen, Chemometr & Analyt Technol, Dept Food Sci, Rolighedsvej 26, DK-1958 Frederiksberg C, Denmark
关键词
foodomics; metabolomics; chemometrics; resveratrol; inductive research; CORONARY-HEART-DISEASE; RED WINE; TRANS-RESVERATROL; METABOLOMICS; PHARMACOKINETICS; BIOAVAILABILITY; INHIBITION; VOLUNTEERS; CHALLENGES; COMPLEX;
D O I
10.1111/nyas.13425
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Resveratrol is probably the most investigated plant secondary metabolite ever. An epidemiological study known as the French paradox showed a correlation between red wine intake and low mortality due to coronary heart diseases, and the red wine substance resveratrol was claimed to play a key role. Since then, several hundred resveratrol studies have been conducted to demonstrate its antioxidant and other beneficial properties. In the foodomics era, considering a complex foodome including over 25,000 substances that make up the human diet, it appears to be outdated to pursue the hunt for biological activities one function/compound at a time. First, nature is multivariate, and the effect of any one molecule will have to be modulated by its carrying matrix, its bioavailability, and synergies with other molecules. Second, a large number of targeted studies have the tendency to become biased, as they tend to retain only the data that the researchers think are relevant and thus increase the chances of spurious correlations. In this concise review, we retrace the research toward a more inductive, holistic, and multivariate path.
引用
收藏
页码:48 / 58
页数:11
相关论文
共 48 条
  • [1] Resveratrol: Anti-Obesity Mechanisms of Action
    Aguirre, Leixuri
    Fernandez-Quintela, Alfredo
    Arias, Noemi
    Portillo, Maria P.
    [J]. MOLECULES, 2014, 19 (11) : 18632 - 18655
  • [2] Resveratrol as a novel treatment for diseases with mTOR pathway hyperactivation
    Alayev, Anya
    Berger, Sara Malka
    Holz, Marina K.
    [J]. RESVERATROL AND HEALTH, 2015, 1348 : 116 - 123
  • [3] Baxter Richard A, 2008, J Cosmet Dermatol, V7, P2, DOI 10.1111/j.1473-2165.2008.00354.x
  • [4] Effect of Resveratrol Treatment on the Pharmacokinetics of Diclofenac in Healthy Human Volunteers
    Bedada, Satish Kumar
    Yellu, Narsimha Reddy
    Neerati, Prasad
    [J]. PHYTOTHERAPY RESEARCH, 2016, 30 (03) : 397 - 401
  • [5] Bradamante S, 2004, CARDIOVASC DRUG REV, V22, P169
  • [6] Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
    Brown, Victoria A.
    Patel, Ketan R.
    Viskaduraki, Maria
    Crowell, James A.
    Perloff, Marjorie
    Booth, Tristan D.
    Vasilinin, Grygoriy
    Sen, Ananda
    Schinas, Anna Maria
    Piccirilli, Gianfranca
    Brown, Karen
    Steward, William P.
    Gescher, Andreas J.
    Brenner, Dean E.
    [J]. CANCER RESEARCH, 2010, 70 (22) : 9003 - 9011
  • [7] Food Analysis in the Postgenomic Era: Foodomics
    Cifuentes, Alejandro
    [J]. ELECTROPHORESIS, 2012, 33 (15) : 2199 - +
  • [8] Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine
    Clouser, Christine L.
    Chauhan, Jay
    Bess, Matthew A.
    van Oploo, Jessica L.
    Zhou, Ding
    Dimick-Gray, Sarah
    Mansky, Louis M.
    Patterson, Steven E.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (21) : 6642 - 6646
  • [9] Resveratrol and obesity: Can resveratrol relieve metabolic disturbances?
    de Ligt, Marlies
    Timmers, Silvie
    Schrauwen, Patrick
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2015, 1852 (06): : 1137 - 1144
  • [10] Challenges in Analyzing the Biological Effects of Resveratrol
    Erdogan, Cihan Suleyman
    Vang, Ole
    [J]. NUTRIENTS, 2016, 8 (06):